A Program for EM Physicians Developed by:



 

 



Pain Management in the Emergency Department

May 17, 2004            2:00 PM to 3:30 PM

Orlando, FL


Purpose:

To educate EM physicians on current aspects of managing patients who present to the ED with painful conditions


Intended Audience:

Members of the FERNE Advisory Board & Emergency Medicine Physicians


Learning Objectives:

At the end of this session, participants will be able to describe the issues surrounding pain management, identify optimal therapeutics available, implement the use of pain assessment tools, and discuss the usefulness of pain protocols in the ED.


Agenda:

Questions Regarding Pain Management in the ED
                        Edward P. Sloan, MD, MPH, FACEP
                        Associate Professor
                        University of Illinois College of Medicine
                        Department of Emergency Medicine
                        Chicago, Illinois


Review of ED Therapeutics for Patient Pain Management
                        Edward A. Panacek, MD, MPH

                        Professor of Medicine
                        Director, Office of Clinical Trials
                        Division of Emergency Medicine
                        Department of Internal Medicine
                        University of California, Davis
                        Davis, California


Innovations in Process Management / Optimizing Patient Management
                        Leslie Zun, MD, MBA, FACEP

                        Mount Sinai Hospital
                        Department of Emergency Medicine
                        Chicago, Illinois


Opportunities and Research Horizons in Pain Management
                        Knox H. Todd, MD, MPH, FACEP

                        Director
                        Pain and Emergency Medicine Initiative
                        Emory University
                        Rollins School of Public Health
                        Atlanta, Georgia

 

This Symposium was supported by an unrestricted educational grant
by Ortho-McNeil Pharmaceutical, Inc.